Cargando…
Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities
The last 12 months have seen the beginning of a new era in the treatment options available for patients with metastatic cutaneous melanoma, a disease previously characterised by its poor prognosis and limited treatment options. Two mechanistically diverse agents have now demonstrated an overall surv...
Autores principales: | Lemech, Charlotte, Arkenau, Hendrik-Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256981/ https://www.ncbi.nlm.nih.gov/pubmed/22253555 http://dx.doi.org/10.4137/CMO.S5855 |
Ejemplares similares
-
Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice
por: Lemech, Charlotte, et al.
Publicado: (2011) -
Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma
por: Jeter, Joanne M., et al.
Publicado: (2012) -
Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations
por: Saggese, Matilde, et al.
Publicado: (2013) -
Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer
por: Rajappa, Senthil, et al.
Publicado: (2018) -
Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence
por: Voskoboynik, Mark, et al.
Publicado: (2014)